The study explored the pharmacological properties of Rb1 and revealed that Rb1 could be an important candidate molecule in the prevention and treatment of disorders associated with stress, including depression, exerting considerable effects and relatively few adverse effects. The gene discussed is RB1; the disease is depressive disorder.